about
Mutations in calmodulin cause ventricular tachycardia and sudden cardiac deathCatecholaminergic polymorphic ventricular tachycardia: An exciting new eraHuman Induced Pluripotent Stem Cell-Derived Cardiomyocytes Afford New Opportunities in Inherited Cardiovascular Disease ModelingTriadin regulation of the ryanodine receptor complexClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsCalsequestrin mutations and catecholaminergic polymorphic ventricular tachycardiaPrevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.Catecholaminergic polymorphic ventricular tachycardia: a current overview.Risk stratification in young patients with channelopathies.Recent developments in the management of patients at risk for sudden cardiac death.Follow-up with exercise test of effort-induced ventricular arrhythmias linked to ryanodine receptor type 2 gene mutations.Paradoxical effect of increased diastolic Ca(2+) release and decreased sinoatrial node activity in a mouse model of catecholaminergic polymorphic ventricular tachycardia.The role of ion channelopathies in sudden cardiac death: implications for clinical practice.Modeling Catecholaminergic Polymorphic Ventricular Tachycardia using Induced Pluripotent Stem Cell-derived Cardiomyocytes.Purkinje cells from RyR2 mutant mice are highly arrhythmogenic but responsive to targeted therapyAcute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts.A mathematical model of spontaneous calcium release in cardiac myocytesTranslating advances in cardiogenetics into effective clinical practice.The effect of K201 on isolated working rabbit heart mechanical function during pharmacologically induced Ca2+ overload.A mechanistic description of gating of the human cardiac ryanodine receptor in a regulated minimal environment.Behavioral influences on cardiac arrhythmiasCardiovascular health, part 2: sports participation in athletes with cardiovascular conditions.Cardiac ion channelopathies and the sudden infant death syndromeModeling a ryanodine receptor N-terminal domain connecting the central vestibule and the corner clamp region.In silico prediction of drug therapy in catecholaminergic polymorphic ventricular tachycardia.Triadin regulates cardiac muscle couplon structure and microdomain Ca(2+) signalling: a path towards ventricular arrhythmias.Calcium Sparks in the Heart: Dynamics and Regulation.In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.Conformational dynamics inside amino-terminal disease hotspot of ryanodine receptorAdeno-associated virus-mediated CASQ2 delivery rescues phenotypic alterations in a patient-specific model of recessive catecholaminergic polymorphic ventricular tachycardia.Cardiac Channelopathies and Sudden Death: Recent Clinical and Genetic AdvancesGenetic basis of malignant channelopathies and ventricular fibrillation in the structurally normal heart.Genetic etiology and evaluation of sudden cardiac death.Efficacy and potency of class I antiarrhythmic drugs for suppression of Ca2+ waves in permeabilized myocytes lacking calsequestrin.Advances in the diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia.Murine Electrophysiological Models of Cardiac Arrhythmogenesis.Human iPSC-derived cardiomyocytes and tissue engineering strategies for disease modeling and drug screening.Postexertional supraventricular tachycardia in children with catecholaminergic polymorphic ventricular tachycardia.CPU228, a derivative of dofetilide, relieves cardiac dysfunction by normalizing FKBP12.6, NADPH oxidase and protein kinase C epsilon in the myocardium.High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
P2860
Q24300356-2F1BCB3D-2126-4967-B78C-27C793256F22Q26747056-57E418D0-6880-47D4-ACBF-4EF066A8FEEEQ26750618-C4CC7F6E-B134-45FE-8A22-2134F52C8522Q26801317-C94D2387-0C26-46AB-91F5-952EB687066AQ27021919-83C0DD77-7AAD-4C90-BFB0-73E50B69F9D0Q28262015-E267DBAF-0FBF-492A-B759-01EAD06F45AAQ30498471-C9A4B6AA-3991-4A52-9E9C-BD3E533265E0Q33157298-92F5DB97-C4F8-4F0F-B4DB-23CBC62C594EQ33158864-14B3C6F4-E484-4E2A-8002-DE7EAA29D588Q33159915-85FBB71A-2D9F-426E-A1B3-0A7B41E762A8Q33160839-35D87C1B-3109-4933-AB5D-06DC5DB8A561Q33161429-CE47BD2B-E2A3-444B-B694-A8851A2C4558Q33162743-78316F90-8F40-4B9A-AA78-A3E89425F2D8Q33163102-B3B7DE83-834F-4100-B544-BF078CCB865AQ34094086-227A7126-30A0-4BFA-BD65-8F8711A7CCA4Q34575281-C59EFA19-AB84-401D-A906-64F6CA895FB7Q34979817-225A2A34-ECE4-41DF-A63E-918AF1CD36B1Q35806084-D2E7C741-1AD3-4C31-B9C1-943F4396BF4EQ35940357-A05C0C9B-9CF7-4BC0-94CB-457ADB197148Q36130339-BD033D87-23C4-4856-9379-BCF51901C281Q36172467-71BA3A2D-6496-4B3D-ACF5-C74D2DBC2FE2Q36225404-21FDAFB0-F510-4A36-87EF-7A92C3995F70Q36486478-8C39D8A0-C71D-439B-8AFF-2290C416896BQ36526379-271B8793-3FD0-4CFE-B53C-4E847664C75EQ36667578-BAD2E45D-DC20-4CF3-9DE9-C229D9C8A5A1Q36786528-C7A4A9F4-87FE-4CCD-A919-3CDC856CD81CQ36913211-589216F7-E120-4AE2-89C2-3CF0A2D334E4Q37005193-34AC6511-A2CE-4364-99E5-FACDA7001771Q37305690-1C7B6B2D-F9EB-490F-998C-19FCC9C0AD6CQ37465870-0EDAEFDD-9BEC-4E19-98BE-237EFDEE80B4Q37728178-C5349957-F351-42E5-8D6C-F75DFD2B838CQ37749844-426BCE10-D70B-4810-9C6B-A586B4872108Q38118161-C626EF1E-9307-4A69-AEFE-B9F77C348145Q38602828-EC41F952-17AF-4798-BA38-CE78E28A37DCQ39022381-ACBF2C55-7707-4A1C-A934-AD3E3A5314EEQ39038606-F3C85F7B-14A6-4E28-9AE3-EC429425B4F0Q39050993-5175C1F0-6C9D-4FF6-8671-E08BD701923EQ39163186-5A76C771-9E30-4A54-8E88-A05819776A1CQ42932530-6BDDC752-4893-45B1-8037-7D8992A061CAQ43182612-5FD694AA-B407-4813-87B0-8B7373D17C84
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Catecholaminergic polymorphic ventricular tachycardia
@ast
Catecholaminergic polymorphic ventricular tachycardia
@en
Catecholaminergic polymorphic ventricular tachycardia
@nl
type
label
Catecholaminergic polymorphic ventricular tachycardia
@ast
Catecholaminergic polymorphic ventricular tachycardia
@en
Catecholaminergic polymorphic ventricular tachycardia
@nl
prefLabel
Catecholaminergic polymorphic ventricular tachycardia
@ast
Catecholaminergic polymorphic ventricular tachycardia
@en
Catecholaminergic polymorphic ventricular tachycardia
@nl
P2093
P3181
P1476
Catecholaminergic polymorphic ventricular tachycardia
@en
P2093
Silvia G Priori
Yanfei Ruan
P3181
P356
10.1016/J.PCAD.2007.10.005
P407
P577
2008-01-01T00:00:00Z